Michail_Petrov-96 /
21 July 2017Americas

FDA tentatively approves Merck biosimilar pending patent suit settlement

The US Food and Drug Administration (FDA) has tentatively approved a Merck biosimilar, pending resolution of a patent dispute.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at